Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-032124
Filing Date
2021-06-11
Accepted
2021-06-11 16:31:01
Documents
72
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0421_enzobiocheminc.htm 10-Q 755716
2 CERTIFICATION f10q0421ex31-1_enzobiochem.htm EX-31.1 18326
3 CERTIFICATION f10q0421ex31-2_enzobiochem.htm EX-31.2 18282
4 CERTIFICATION f10q0421ex32-1_enzobiochem.htm EX-32.1 6431
5 CERTIFICATION f10q0421ex32-2_enzobiochem.htm EX-32.2 6388
  Complete submission text file 0001213900-21-032124.txt   4882385

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20210430.xml EX-101.INS 996855
7 XBRL SCHEMA FILE enz-20210430.xsd EX-101.SCH 60047
8 XBRL CALCULATION FILE enz-20210430_cal.xml EX-101.CAL 43180
9 XBRL DEFINITION FILE enz-20210430_def.xml EX-101.DEF 245185
10 XBRL LABEL FILE enz-20210430_lab.xml EX-101.LAB 488629
11 XBRL PRESENTATION FILE enz-20210430_pre.xml EX-101.PRE 256854
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 211011700
SIC: 8071 Services-Medical Laboratories